Atlas Trials

A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy

Clinical trial NCT01302041 · COMPLETED

Trial details

NCT number
NCT01302041
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2011-05-06
Primary completion
2012-07-29
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.